Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / SHS
-
Total 13F shares
-
30,701,203
-
Share change
-
-1,946,580
-
Total reported value
-
$16,361,489
-
Put/Call ratio
-
46%
-
Price per share
-
$0.53
-
Number of holders
-
46
-
Value change
-
-$1,126,893
-
Number of buys
-
19
-
Number of sells
-
18
Institutional Holders of NABRIVA THERAPEUTICS PLC - SHS as of Q3 2020
As of 30 Sep 2020,
NABRIVA THERAPEUTICS PLC - SHS was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,701,203 shares.
The largest 10 holders included
FMR LLC, FRAZIER MANAGEMENT LLC, ORBIMED ADVISORS LLC, Aisling Capital Management LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Rock Springs Capital Management LP, STATE STREET CORP, KESTRA PRIVATE WEALTH SERVICES, LLC, WINTON GROUP Ltd, and Values First Advisors, Inc..
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.